Key result
Oxprenolol before rock climbing lowers heart rate by ~46 bpm vs placebo, preventing plasma adrenaline increases.
Why the study?
Does oxprenolol reduce heart rate and plasma catecholamine concentrations in healthy men during rock climbing?
Does oxprenolol reduce heart rate and plasma catecholamine concentrations in healthy men during rock climbing?
Beta-blockade with oxprenolol blunts the heart rate and adrenaline response to rock climbing, suggesting the sport induces primarily psychological rather than physical stress.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for psychological stress in climbing; should not change practice or guidelines without larger trials.
Observations are presented on the electrocardiogram and plasma catecholamine concentrations of 11 healthy men monitored during two rock climbing ascents. A placebo was administered prior to the first climb and an oral dose of the beta blocking agent oxprenolol ("Trasicor") prior to the second. Mean heart rates were 166 (+/- 20.4 SD) and 120 (+/- 10.2) respectively. Median plasma adrenaline concentrations were 0.05 microgram/1 and 0.33 microgram/1 before and after the climbs following the placebo. No significant difference was observed in the adrenaline concentrations before and after climbing following oxprenolol, or of noradrenaline concentrations on either occasion. These results are interpreted as suggesting that this popular sport represents more an anxiety-type of psychological stress than a physical stress and as such is likely to increase moral fibre rather than muscle fibre.
No takes yet. Share an insight, caveat, or question.
Williams et al. (1978) studied Healthy (n=11). Oxprenolol vs. Placebo was evaluated on Mean heart rate. Oxprenolol administered prior to rock climbing resulted in a lower mean heart rate (120 bpm) compared to placebo (166 bpm) and prevented significant increases in plasma adrenaline.
Synapse has enriched 10 related papers. Consider them for comparative context: